Evidence map›Paper›PMID 37162726›Full record

ArticleMetabolic brain disease2023

Exome sequence analysis of rare frequency variants in Late-Onset Alzheimer Disease.

Sudharsana Sundarrajan, Arthi Venkatesan, Udhaya Kumar S, Mohanraj Gopikrishnan, Iftikhar Aslam Tayubi, M Aditya, Gowrishankar Bychapur Siddaiah, C George Priya Doss, Hatem Zayed

Open access · hybridAbstract read
In one paragraph

Article in Metabolic brain disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Mapping cross-domain drivers of Alzheimer's disease risk through integrated network analysis.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  2. Article
  3. Alzheimer's disease multi-ancestry genome-wide interaction and stratified study with smoking.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Sudharsana SundarrajanIndependent Researcher, Amsterdam, Netherlands.ORCID http://orcid.org/0000-0002-2828-0310
Arthi VenkatesanBIOVIA Specialist, VIAS 3D, MG Road, Bengaluru, 560001, Karnataka, India.ORCID http://orcid.org/0000-0002-2923-3946
Udhaya Kumar SLaboratory of Integrative Genomics, Department of Integrative Biology, School of BioSciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.ORCID http://orcid.org/0000-0002-6639-3746
Mohanraj GopikrishnanLaboratory of Integrative Genomics, Department of Integrative Biology, School of BioSciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.ORCID http://orcid.org/0000-0002-6758-443X
Iftikhar Aslam TayubiDepartment of Computer Science, Faculty of Computing and Information Technology, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.ORCID http://orcid.org/0000-0002-2797-8522
M AdityaDepartment of Biotechnology, Siddaganga Institute of Technology, Tumkur, Karnataka, 572103, India.ORCID http://orcid.org/0009-0000-8783-4355
Gowrishankar Bychapur SiddaiahDepartment of Biotechnology, Siddaganga Institute of Technology, Tumkur, Karnataka, 572103, India.ORCID http://orcid.org/0000-0002-9167-5788
C George Priya DossLaboratory of Integrative Genomics, Department of Integrative Biology, School of BioSciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India. georgepriyadoss@vit.ac.in.ORCID http://orcid.org/0000-0002-5971-8290
Hatem ZayedDepartment of Biomedical Sciences College of Health Sciences, QU Health, Qatar University, Doha, Qatar. hatem.zayed@qu.edu.qa.ORCID http://orcid.org/0000-0001-8838-6638
Vellore Institute of Technology University · INSiddaganga Institute of Technology · INKing Abdulaziz University · SAQatar University · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer disease (AD) is a leading cause of dementia in elderly patients who continue to live between 3 and 11 years of diagnosis. A steep rise in AD incidents is observed in the elderly population in East-Asian countries. The disease progresses through several changes, including memory loss, behavioural issues, and cognitive impairment. The etiology of AD is hard to determine because of its complex nature. The whole exome sequences of late-onset AD (LOAD) patients of Korean origin are investigated to identify rare genetic variants that may influence the complex disorder. Computational annotation was performed to assess the function of candidate variants in LOAD. The in silico pathogenicity prediction tools such as SIFT, Polyphen-2, Mutation Taster, CADD, LRT, PROVEAN, DANN, VEST3, fathmm-MKL, GERP +  + , SiPhy, phastCons, and phyloP identified around 17 genes harbouring deleterious variants. The variants in the ALDH3A2 and RAD54B genes were pathogenic, while in 15 other genes were predicted to be variants of unknown significance. These variants can be potential risk candidates contributing to AD. In silico computational techniques such as molecular docking, molecular dynamic simulation and steered molecular dynamics were carried out to understand the structural insights of RAD54B with ATP. The simulation of mutant (T459N) RAD54B with ATP revealed reduced binding strength of ATP at its binding site. In addition, lower binding free energy was observed when compared to the wild-type RAD54B. Our study shows that the identified uncommon variants are linked to AD and could be probable predisposing genetic factors of LOAD.

Indexed as

Alzheimer DiseaseAdenosine TriphosphateAgedExomeHumansMolecular Docking SimulationSequence AnalysisAdenosine TriphosphateAlzheimer diseaseEast-AsianExomeLOADMolecular Dynamics simulationRare variants

Identifiers

PMID37162726
PMCPMC10348954
OpenAlexW4376121337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.